{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T07:03:32Z","timestamp":1790147012694,"version":"4.0.1"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"18","license":[{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"HHS | National Institutes of Health","doi-asserted-by":"publisher","award":["AI101935"],"award-info":[{"award-number":["AI101935"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"HHS | National Institutes of Health","doi-asserted-by":"publisher","award":["AI124346"],"award-info":[{"award-number":["AI124346"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"HHS | National Institutes of Health","doi-asserted-by":"publisher","award":["AI160179"],"award-info":[{"award-number":["AI160179"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"HHS | National Institutes of Health","doi-asserted-by":"publisher","award":["AR056296"],"award-info":[{"award-number":["AR056296"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"HHS | National Institutes of Health","doi-asserted-by":"publisher","award":["CA253095"],"award-info":[{"award-number":["CA253095"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"HHS | National Institutes of Health","doi-asserted-by":"publisher","award":["CA23944"],"award-info":[{"award-number":["CA23944"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012524","name":"American Lebanese Syrian Associated Charities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012524","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Pathogens, tissue damage, and cellular stress are detected by innate immune sensor molecules to drive inflammatory signaling and cell death. Mutations in\u00a0the sensor NLRP1 are associated with inflammatory disease, but the regulation of this sensor is not well understood. Here, we find that LPS, a TLR4 ligand and canonical activator of innate immunity, inhibits NLRP1-mediated caspase activation, IL-18 release, and inflammatory cell death, PANoptosis. This inhibition requires TRIF but not MyD88, implicating TRIF-dependent TLR signaling. IRF3 is also required, suggesting an essential role for type I IFN signaling. Indeed, IFN-\u03b2 production or treatment with exogenous IFN-\u03b1 or IFN-\u03b2 inhibits NLRP1-dependent PANoptosis in mouse bone marrow-derived macrophages and human macrophages and monocytes. Mechanistically,\n                    <jats:italic>Nlrp1b<\/jats:italic>\n                    \/\n                    <jats:italic>NLRP1<\/jats:italic>\n                    expression is significantly reduced in LPS- or type I IFN-treated cells. Overall, our study identifies a TLR4\u2013TRIF\u2013IRF3 signaling axis that induces type I IFNs to negatively regulate\n                    <jats:italic>NLRP1<\/jats:italic>\n                    transcription, thereby blocking NLRP1-driven, caspase-1\/caspase-8\/RIPK3\u2013dependent PANoptosis. These findings suggest type I IFNs as a potential therapeutic strategy for NLRP1-driven inflammatory diseases.\n                  <\/jats:p>","DOI":"10.1038\/s44319-026-00888-0","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T18:15:09Z","timestamp":1785348909000},"page":"5214-5232","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["IFN-\u03b1 and IFN-\u03b2 inhibit NLRP1-driven PANoptosis"],"prefix":"10.1038","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3609-833X","authenticated-orcid":false,"given":"Bhesh Raj","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harisankeerth","family":"Mummareddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangappa B","family":"Chadchan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3332-1017","authenticated-orcid":false,"given":"Roman","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9374-103X","authenticated-orcid":false,"given":"Chadi A","family":"EI Farran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6395-6443","authenticated-orcid":false,"given":"Thirumala-Devi","family":"Kanneganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"key":"888_CR1","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S1074-7613(00)80596-8","volume":"9","author":"O Adachi","year":"1998","unstructured":"Adachi O, Kawai T, Takeda K, Matsumoto M, Tsutsui H, Sakagami M, Nakanishi K, Akira S (1998) Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9:143\u2013150","journal-title":"Immunity"},{"key":"888_CR2","doi-asserted-by":"publisher","first-page":"11657","DOI":"10.1073\/pnas.92.25.11657","volume":"92","author":"WC Au","year":"1995","unstructured":"Au WC, Moore PA, Lowther W, Juang YT, Pitha PM (1995) Identification of a member of the interferon regulatory factor family that binds to the interferon-stimulated response element and activates expression of interferon-induced genes. Proc Natl Acad Sci USA 92:11657\u201311661","journal-title":"Proc Natl Acad Sci USA"},{"key":"888_CR3","doi-asserted-by":"publisher","first-page":"45194","DOI":"10.1074\/jbc.M400726200","volume":"279","author":"BJ Barnes","year":"2004","unstructured":"Barnes BJ, Richards J, Mancl M, Hanash S, Beretta L, Pitha PM (2004) Global and distinct targets of IRF-5 and IRF-7 during innate response to viral infection. J Biol Chem 279:45194\u201345207","journal-title":"J Biol Chem"},{"key":"888_CR4","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.molimm.2003.10.005","volume":"40","author":"B Beutler","year":"2004","unstructured":"Beutler B (2004) Innate immunity: an overview. Mol Immunol 40:845\u2013859","journal-title":"Mol Immunol"},{"key":"888_CR5","doi-asserted-by":"publisher","first-page":"e1006052","DOI":"10.1371\/journal.ppat.1006052","volume":"12","author":"J Chavarr\u00eda-Smith","year":"2016","unstructured":"Chavarr\u00eda-Smith J, Mitchell PS, Ho AM, Daugherty MD, Vance RE (2016) Functional and evolutionary analyses identify proteolysis as a general mechanism for NLRP1 inflammasome activation. PLos Pathog 12:e1006052","journal-title":"PLos Pathog"},{"key":"888_CR6","doi-asserted-by":"publisher","first-page":"e1003452","DOI":"10.1371\/journal.ppat.1003452","volume":"9","author":"J Chavarr\u00eda-Smith","year":"2013","unstructured":"Chavarr\u00eda-Smith J, Vance RE (2013) Direct proteolytic cleavage of NLRP1B is necessary and sufficient for inflammasome activation by anthrax lethal factor. PLoS Pathog 9:e1003452","journal-title":"PLoS Pathog"},{"key":"888_CR7","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3389\/fcimb.2020.00237","volume":"10","author":"S Christgen","year":"2020","unstructured":"Christgen S, Zheng M, Kesavardhana S, Karki R, Malireddi RKS, Banoth B, Place DE, Briard B, Sharma BR, Tuladhar S et al (2020) Identification of the PANoptosome: a molecular platform triggering pyroptosis, apoptosis, and necroptosis (PANoptosis). Front Cell Infect Microbiol 10:237","journal-title":"Front Cell Infect Microbiol"},{"key":"888_CR8","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1126\/science.aau1208","volume":"364","author":"AJ Chui","year":"2019","unstructured":"Chui AJ, Okondo MC, Rao SD, Gai K, Griswold AR, Johnson DC, Ball DP, Taabazuing CY, Orth EL, Vittimberga BA et al (2019) N-terminal degradation activates the NLRP1B inflammasome. Science 364:82\u201385","journal-title":"Science"},{"key":"888_CR9","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1136\/ard.2010.131243","volume":"70","author":"P Dieude","year":"2011","unstructured":"Dieude P, Guedj M, Wipff J, Ruiz B, Riemekasten G, Airo P, Melchers I, Hachulla E, Cerinic MM, Diot E et al (2011) NLRP1 influences the systemic sclerosis phenotype: a new clue for the contribution of innate immunity in systemic sclerosis-related fibrosing alveolitis pathogenesis. Ann Rheum Dis 70:668\u2013674","journal-title":"Ann Rheum Dis"},{"key":"888_CR10","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, Gingeras TR (2013) STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29:15\u201321","journal-title":"Bioinformatics"},{"key":"888_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1455","volume":"12","author":"CA Docherty","year":"2023","unstructured":"Docherty CA, Fernando AJ, Rosli S, Lam M, Dolle RE, Navia MA, Farquhar R, La France D, Tate MD, Murphy CK et al (2023) A novel dual NLRP1 and NLRP3 inflammasome inhibitor for the treatment of inflammatory diseases. Clin Transl Immunol 12:e1455","journal-title":"Clin Transl Immunol"},{"key":"888_CR12","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1016\/j.jid.2022.04.004","volume":"142","author":"G Fenini","year":"2022","unstructured":"Fenini G, Karakaya T, Hennig P, Di Filippo M, Slaufova M, Beer HD (2022) NLRP1 inflammasome activation in keratinocytes: increasing evidence of important roles in inflammatory skin diseases and immunity. J Invest Dermatol 142:2313\u20132322","journal-title":"J Invest Dermatol"},{"key":"888_CR13","doi-asserted-by":"publisher","first-page":"25030","DOI":"10.1074\/jbc.M112.378323","volume":"287","author":"JN Finger","year":"2012","unstructured":"Finger JN, Lich JD, Dare LC, Cook MN, Brown KK, Duraiswami C, Bertin J, Gough PJ (2012) Autolytic proteolysis within the function to find domain (FIIND) is required for NLRP1 inflammasome activity. J Biol Chem 287:25030\u201325037","journal-title":"J Biol Chem"},{"key":"888_CR14","doi-asserted-by":"publisher","first-page":"e1002659","DOI":"10.1371\/journal.ppat.1002659","volume":"8","author":"BC Frew","year":"2012","unstructured":"Frew BC, Joag VR, Mogridge J (2012) Proteolytic processing of Nlrp1b is required for inflammasome activity. PLoS Pathog 8:e1002659","journal-title":"PLoS Pathog"},{"key":"888_CR15","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1128\/jvi.63.6.2785-2789.1989","volume":"63","author":"S Gessani","year":"1989","unstructured":"Gessani S, Belardelli F, Pecorelli A, Puddu P, Baglioni C (1989) Bacterial lipopolysaccharide and gamma interferon induce transcription of beta interferon mRNA and interferon secretion in murine macrophages. J Virol 63:2785\u20132789","journal-title":"J Virol"},{"key":"888_CR16","doi-asserted-by":"crossref","unstructured":"Grandemange E, Sanchez E, Louis-Plence P, Rittore C, Reed J, Touitou I, Genevieve D (2015) NLRP1 mutations cause autoinflammatory diseases in human. Pediatr Rheumatol Online J 13:O22","DOI":"10.1186\/1546-0096-13-S1-O22"},{"key":"888_CR17","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1136\/annrheumdis-2016-210021","volume":"76","author":"S Grandemange","year":"2017","unstructured":"Grandemange S, Sanchez E, Louis-Plence P, Tran Mau-Them F, Bessis D, Coubes C, Frouin E, Seyger M, Girard M, Puechberty J et al (2017) A new autoinflammatory and autoimmune syndrome associated with NLRP1 mutations: NAIAD (NLRP1-associated autoinflammation with arthritis and dyskeratosis). Ann Rheum Dis 76:1191\u20131198","journal-title":"Ann Rheum Dis"},{"key":"888_CR18","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","volume":"32","author":"Z Gu","year":"2016","unstructured":"Gu Z, Eils R, Schlesner M (2016) Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics 32:2847\u20132849","journal-title":"Bioinformatics"},{"key":"888_CR19","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1126\/science.1240988","volume":"341","author":"JA Hagar","year":"2013","unstructured":"Hagar JA, Powell DA, Aachoui Y, Ernst RK, Miao EA (2013) Cytoplasmic LPS activates caspase-11: implications in TLR4-independent endotoxic shock. Science 341:1250\u20131253","journal-title":"Science"},{"key":"888_CR20","doi-asserted-by":"publisher","first-page":"15652","DOI":"10.1074\/jbc.M311629200","volume":"279","author":"KJ Han","year":"2004","unstructured":"Han KJ, Su X, Xu LG, Bin LH, Zhang J, Shu HB (2004) Mechanisms of the TRIF-induced interferon-stimulated response element and NF-kappaB activation and apoptosis pathways. J Biol Chem 279:15652\u201315661","journal-title":"J Biol Chem"},{"key":"888_CR21","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","volume":"42","author":"Y Hao","year":"2024","unstructured":"Hao Y, Stuart T, Kowalski MH, Choudhary S, Hoffman P, Hartman A, Srivastava A, Molla G, Madad S, Fernandez-Granda C et al (2024) Dictionary learning for integrative, multimodal and scalable single-cell analysis. Nat Biotechnol 42:293\u2013304","journal-title":"Nat Biotechnol"},{"key":"888_CR22","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/s41586-021-03350-4","volume":"592","author":"LR Hollingsworth","year":"2021","unstructured":"Hollingsworth LR, Sharif H, Griswold AR, Fontana P, Mintseris J, Dagbay KB, Paulo JA, Gygi SP, Bachovchin DA, Wu H (2021) DPP9 sequesters the C terminus of NLRP1 to repress inflammasome activation. Nature 592:778\u2013783","journal-title":"Nature"},{"key":"888_CR23","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/nri1900","volume":"6","author":"K Honda","year":"2006","unstructured":"Honda K, Taniguchi T (2006) IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol 6:644\u2013658","journal-title":"Nat Rev Immunol"},{"key":"888_CR24","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/nature03464","volume":"434","author":"K Honda","year":"2005","unstructured":"Honda K, Yanai H, Negishi H, Asagiri M, Sato M, Mizutani T, Shimada N, Ohba Y, Takaoka A, Yoshida N et al (2005) IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434:772\u2013777","journal-title":"Nature"},{"key":"888_CR25","doi-asserted-by":"publisher","first-page":"3749","DOI":"10.4049\/jimmunol.162.7.3749","volume":"162","author":"K Hoshino","year":"1999","unstructured":"Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y, Takeda K, Akira S (1999) Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 162:3749\u20133752","journal-title":"J Immunol"},{"key":"888_CR26","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adp7160","volume":"10","author":"G Hou","year":"2024","unstructured":"Hou G, Chen Y, Lei H, Lu Y, Liu L, Han Z, Sun S, Li J, Cheng L (2024) Bimetallic peroxide nanoparticles induce PANoptosis by disrupting ion homeostasis for enhanced immunotherapy. Sci Adv 10:eadp7160","journal-title":"Sci Adv"},{"key":"888_CR27","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/nri3581","volume":"14","author":"LB Ivashkiv","year":"2014","unstructured":"Ivashkiv LB, Donlin LT (2014) Regulation of type I interferon responses. Nat Rev Immunol 14:36\u201349","journal-title":"Nat Rev Immunol"},{"key":"888_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/SQB.1989.054.01.003","volume":"54","author":"CA Janeway Jr","year":"1989","unstructured":"Janeway CA Jr (1989) Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb Symp Quant Biol 54:1\u201313","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"888_CR29","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1007\/s12016-020-08798-2","volume":"59","author":"J Jiang","year":"2020","unstructured":"Jiang J, Zhao M, Chang C, Wu H, Lu Q (2020) Type I Interferons in the pathogenesis and treatment of autoimmune diseases. Clin Rev Allergy Immunol 59:248\u2013272","journal-title":"Clin Rev Allergy Immunol"},{"key":"888_CR30","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/jid.2009.273","volume":"130","author":"Y Jin","year":"2010","unstructured":"Jin Y, Riccardi SL, Gowan K, Fain PR, Spritz RA (2010) Fine-mapping of vitiligo susceptibility loci on chromosomes 7 and 9 and interactions with NLRP1 (NALP1). J Invest Dermatol 130:774\u2013783","journal-title":"J Invest Dermatol"},{"key":"888_CR31","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/nbt.4042","volume":"36","author":"HM Kang","year":"2018","unstructured":"Kang HM, Subramaniam M, Targ S, Nguyen M, Maliskova L, McCarthy E, Wan E, Wong S, Byrnes L, Lanata CM et al (2018) Multiplexed droplet single-cell RNA-sequencing using natural genetic variation. Nat Biotechnol 36:89\u201394","journal-title":"Nat Biotechnol"},{"key":"888_CR32","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/imr.12912","volume":"297","author":"TD Kanneganti","year":"2020","unstructured":"Kanneganti TD (2020) Intracellular innate immune receptors: Life inside the cell. Immunol Rev 297:5\u201312","journal-title":"Immunol Rev"},{"key":"888_CR33","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nature04517","volume":"440","author":"TD Kanneganti","year":"2006","unstructured":"Kanneganti TD, Ozoren N, Body-Malapel M, Amer A, Park JH, Franchi L, Whitfield J, Barchet W, Colonna M, Vandenabeele P et al (2006) Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin\/Nalp3. Nature 440:233\u2013236","journal-title":"Nature"},{"key":"888_CR34","doi-asserted-by":"crossref","unstructured":"Karki R, Lee S, Mall R, Pandian N, Wang Y, Sharma BR, Malireddi RS, Yang D, Trifkovic S, Steele JA et al (2022) ZBP1-dependent inflammatory cell death, PANoptosis, and cytokine storm disrupt IFN therapeutic efficacy during coronavirus infection. Sci Immunol 7:eabo6294","DOI":"10.1126\/sciimmunol.abo6294"},{"key":"888_CR35","doi-asserted-by":"publisher","first-page":"e136720","DOI":"10.1172\/jci.insight.136720","volume":"5","author":"R Karki","year":"2020","unstructured":"Karki R, Sharma BR, Lee E, Banoth B, Malireddi RKS, Samir P, Tuladhar S, Mummareddy H, Burton AR, Vogel P et al (2020) Interferon regulatory factor 1 regulates PANoptosis to prevent colorectal cancer. JCI insight 5:e136720","journal-title":"JCI insight"},{"key":"888_CR36","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.cell.2020.11.025","volume":"184","author":"R Karki","year":"2021","unstructured":"Karki R, Sharma BR, Tuladhar S, Williams EP, Zalduondo L, Samir P, Zheng M, Sundaram B, Banoth B, Malireddi RKS et al (2021a) Synergism of TNF-alpha and IFN-gamma triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes. Cell 184:149\u2013168.e17","journal-title":"Cell"},{"key":"888_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109858","volume":"37","author":"R Karki","year":"2021","unstructured":"Karki R, Sundaram B, Sharma BR, Lee S, Malireddi RKS, Nguyen LN, Christgen S, Zheng M, Wang Y, Samir P et al (2021b) ADAR1 restricts ZBP1-mediated immune response and PANoptosis to promote tumorigenesis. Cell Rep 37:109858","journal-title":"Cell Rep"},{"key":"888_CR38","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.immuni.2024.03.004","volume":"57","author":"T Kawai","year":"2024","unstructured":"Kawai T, Ikegawa M, Ori D, Akira S (2024) Decoding Toll-like receptors: Recent insights and perspectives in innate immunity. Immunity 57:649\u2013673","journal-title":"Immunity"},{"key":"888_CR39","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nature10558","volume":"479","author":"N Kayagaki","year":"2011","unstructured":"Kayagaki N, Warming S, Lamkanfi M, Vande Walle L, Louie S, Dong J, Newton K, Qu Y, Liu J, Heldens S et al (2011) Non-canonical inflammasome activation targets caspase-11. Nature 479:117\u2013121","journal-title":"Nature"},{"key":"888_CR40","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1126\/science.1240248","volume":"341","author":"N Kayagaki","year":"2013","unstructured":"Kayagaki N, Wong MT, Stowe IB, Ramani SR, Gonzalez LC, Akashi-Takamura S, Miyake K, Zhang J, Lee WP, Muszynski A et al (2013) Noncanonical inflammasome activation by intracellular LPS independent of TLR4. Science 341:1246\u20131249","journal-title":"Science"},{"key":"888_CR41","doi-asserted-by":"publisher","first-page":"5536","DOI":"10.1016\/j.cell.2023.11.002","volume":"186","author":"DI Kotov","year":"2023","unstructured":"Kotov DI, Lee OV, Fattinger SA, Langner CA, Guillen JV, Peters JM, Moon A, Burd EM, Witt KC, Stetson DB et al (2023) Early cellular mechanisms of type I interferon-driven susceptibility to tuberculosis. Cell 186:5536\u20135553.e22","journal-title":"Cell"},{"key":"888_CR42","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.4049\/jimmunol.1201065","volume":"189","author":"M Kovarova","year":"2012","unstructured":"Kovarova M, Hesker PR, Jania L, Nguyen M, Snouwaert JN, Xiang Z, Lommatzsch SE, Huang MT, Ting JP, Koller BH (2012) NLRP1-dependent pyroptosis leads to acute lung injury and morbidity in mice. J Immunol 189:2006\u20132016","journal-title":"J Immunol"},{"key":"888_CR43","doi-asserted-by":"publisher","first-page":"aag2045","DOI":"10.1126\/sciimmunol.aag2045","volume":"1","author":"T Kuriakose","year":"2016","unstructured":"Kuriakose T, Man SM, Malireddi RK, Karki R, Kesavardhana S, Place DE, Neale G, Vogel P, Kanneganti TD (2016) ZBP1\/DAI is an innate sensor of influenza virus triggering the NLRP3 inflammasome and programmed cell death pathways. Sci Immunol 1:aag2045","journal-title":"Sci Immunol"},{"key":"888_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1023567","volume":"13","author":"FFY Lee","year":"2022","unstructured":"Lee FFY, Alper S (2022) Alternative pre-mRNA splicing as a mechanism for terminating Toll-like Receptor signaling. Front Immunol 13:1023567","journal-title":"Front Immunol"},{"key":"888_CR45","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41586-021-03875-8","volume":"597","author":"S Lee","year":"2021","unstructured":"Lee S, Karki R, Wang Y, Nguyen LN, Kalathur RC, Kanneganti TD (2021) AIM2 forms a complex with pyrin and ZBP1 to drive PANoptosis and host defence. Nature 597:415\u2013419","journal-title":"Nature"},{"key":"888_CR46","doi-asserted-by":"publisher","first-page":"e1002638","DOI":"10.1371\/journal.ppat.1002638","volume":"8","author":"JL Levinsohn","year":"2012","unstructured":"Levinsohn JL, Newman ZL, Hellmich KA, Fattah R, Getz MA, Liu S, Sastalla I, Leppla SH, Moayeri M (2012) Anthrax lethal factor cleavage of Nlrp1 is required for activation of the inflammasome. PLoS Pathog 8:e1002638","journal-title":"PLoS Pathog"},{"key":"888_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S (2014) Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15:550","journal-title":"Genome Biol"},{"key":"888_CR48","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/ni.3118","volume":"16","author":"SM Man","year":"2015","unstructured":"Man SM, Karki R, Malireddi RK, Neale G, Vogel P, Yamamoto M, Lamkanfi M, Kanneganti TD (2015) The transcription factor IRF1 and guanylate-binding proteins target activation of the AIM2 inflammasome by Francisella infection. Nat Immunol 16:467\u2013475","journal-title":"Nat Immunol"},{"key":"888_CR49","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.cell.2016.09.012","volume":"167","author":"SM Man","year":"2016","unstructured":"Man SM, Karki R, Sasai M, Place DE, Kesavardhana S, Temirov J, Frase S, Zhu Q, Malireddi RKS, Kuriakose T et al (2016) IRGB10 liberates bacterial ligands for sensing by the AIM2 and caspase-11-NLRP3 inflammasomes. Cell 167:382\u2013396.e17","journal-title":"Cell"},{"key":"888_CR50","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","volume":"10","author":"F Martinon","year":"2002","unstructured":"Martinon F, Burns K, Tschopp J (2002) The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 10:417\u2013426","journal-title":"Mol Cell"},{"key":"888_CR51","doi-asserted-by":"publisher","first-page":"R118","DOI":"10.1016\/S0960-9822(01)00056-2","volume":"11","author":"F Martinon","year":"2001","unstructured":"Martinon F, Hofmann K, Tschopp J (2001) The pyrin domain: a possible member of the death domain-fold family implicated in apoptosis and inflammation. Curr Biol 11:R118\u2013R120","journal-title":"Curr Biol"},{"key":"888_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-03536-9","volume":"7","author":"A Maver","year":"2017","unstructured":"Maver A, Lavtar P, Ristic S, Stopinsek S, Simcic S, Hocevar K, Sepcic J, Drulovic J, Pekmezovic T, Novakovic I et al (2017) Identification of rare genetic variation of NLRP1 gene in familial multiple sclerosis. Sci Rep 7:3715","journal-title":"Sci Rep"},{"key":"888_CR53","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/nri3787","volume":"15","author":"F McNab","year":"2015","unstructured":"McNab F, Mayer-Barber K, Sher A, Wack A, O\u2019Garra A (2015) Type I interferons in infectious disease. Nat Rev Immunol 15:87\u2013103","journal-title":"Nat Rev Immunol"},{"key":"888_CR54","doi-asserted-by":"publisher","first-page":"D966","DOI":"10.1093\/nar\/gkae1078","volume":"53","author":"JM Mudge","year":"2025","unstructured":"Mudge JM, Carbonell-Sala S, Diekhans M, Martinez JG, Hunt T, Jungreis I, Loveland JE, Arnan C, Barnes I, Bennett R et al (2025) GENCODE 2025: reference gene annotation for human and mouse. Nucleic Acids Res 53:D966\u2013D975","journal-title":"Nucleic Acids Res"},{"key":"888_CR55","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1126\/science.8009221","volume":"264","author":"U Muller","year":"1994","unstructured":"Muller U, Steinhoff U, Reis LF, Hemmi S, Pavlovic J, Zinkernagel RM, Aguet M (1994) Functional role of type I and type II interferons in antiviral defense. Science 264:1918\u20131921","journal-title":"Science"},{"key":"888_CR56","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/0092-8674(94)90154-6","volume":"77","author":"D Novick","year":"1994","unstructured":"Novick D, Cohen B, Rubinstein M (1994) The human interferon alpha\/beta receptor: characterization and molecular cloning. Cell 77:391\u2013400","journal-title":"Cell"},{"key":"888_CR57","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nchembio.2229","volume":"13","author":"MC Okondo","year":"2017","unstructured":"Okondo MC, Johnson DC, Sridharan R, Go EB, Chui AJ, Wang MS, Poplawski SE, Wu W, Liu Y, Lai JH et al (2017) DPP8 and DPP9 inhibition induces pro-caspase-1-dependent monocyte and macrophage pyroptosis. Nat Chem Biol 13:46\u201353","journal-title":"Nat Chem Biol"},{"key":"888_CR58","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.chembiol.2017.12.013","volume":"25","author":"MC Okondo","year":"2018","unstructured":"Okondo MC, Rao SD, Taabazuing CY, Chui AJ, Poplawski SE, Johnson DC, Bachovchin DA (2018) Inhibition of Dpp8\/9 Activates the Nlrp1b Inflammasome. Cell Chem Biol 25:262\u2013267.e265","journal-title":"Cell Chem Biol"},{"key":"888_CR59","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1002\/glia.22608","volume":"62","author":"T Owens","year":"2014","unstructured":"Owens T, Khorooshi R, Wlodarczyk A, Asgari N (2014) Interferons in the central nervous system: a few instruments play many tunes. Glia 62:339\u2013355","journal-title":"Glia"},{"key":"888_CR60","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/nri1604","volume":"5","author":"LC Platanias","year":"2005","unstructured":"Platanias LC (2005) Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol 5:375\u2013386","journal-title":"Nat Rev Immunol"},{"key":"888_CR61","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1097\/WAD.0b013e318231a8ac","volume":"26","author":"A Pontillo","year":"2012","unstructured":"Pontillo A, Catamo E, Arosio B, Mari D, Crovella S (2012) NALP1\/NLRP1 genetic variants are associated with Alzheimer disease. Alzheimer Dis Assoc Disord 26:277\u2013281","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"888_CR62","doi-asserted-by":"crossref","unstructured":"Sandstrom A, Mitchell PS, Goers L, Mu EW, Lesser CF, Vance RE (2019) Functional degradation: a mechanism of NLRP1 inflammasome activation by diverse pathogen enzymes. Science 364:eaau1330","DOI":"10.1126\/science.aau1330"},{"key":"888_CR63","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/S1074-7613(00)00053-4","volume":"13","author":"M Sato","year":"2000","unstructured":"Sato M, Suemori H, Hata N, Asagiri M, Ogasawara K, Nakao K, Nakaya T, Katsuki M, Noguchi S, Tanaka N et al (2000) Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha\/beta gene induction. Immunity 13:539\u2013548","journal-title":"Immunity"},{"key":"888_CR64","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.1074\/jbc.273.5.2714","volume":"273","author":"SL Schafer","year":"1998","unstructured":"Schafer SL, Lin R, Moore PA, Hiscott J, Pitha PM (1998) Regulation of type I interferon gene expression by interferon regulatory factor-3. J Biol Chem 273:2714\u20132720","journal-title":"J Biol Chem"},{"key":"888_CR65","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1093\/jimmun\/vkaf042","volume":"214","author":"BR Sharma","year":"2025","unstructured":"Sharma BR, Choudhury SM, Abdelaal HM, Wang Y, Kanneganti TD (2025) Innate immune sensor NLRP3 drives PANoptosome formation and PANoptosis. J Immunol 214:1236\u20131246","journal-title":"J Immunol"},{"key":"888_CR66","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/s41590-021-00886-5","volume":"22","author":"BR Sharma","year":"2021","unstructured":"Sharma BR, Kanneganti TD (2021) NLRP3 inflammasome in cancer and metabolic diseases. Nat Immunol 22:550\u2013559","journal-title":"Nat Immunol"},{"key":"888_CR67","doi-asserted-by":"crossref","unstructured":"Sharma BR, Karki R, Rajesh Y, Kanneganti TD (2023) Immune regulator IRF1 contributes to ZBP1-, AIM2-, RIPK1-, and NLRP12-PANoptosome activation and inflammatory cell death (PANoptosis). J Biol Chem 299:105141","DOI":"10.1016\/j.jbc.2023.105141"},{"key":"888_CR68","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1002\/art.33370","volume":"64","author":"J Sui","year":"2012","unstructured":"Sui J, Li H, Fang Y, Liu Y, Li M, Zhong B, Yang F, Zou Q, Wu Y (2012) NLRP1 gene polymorphism influences gene transcription and is a risk factor for rheumatoid arthritis in Han Chinese. Arthritis Rheum 64:647\u2013654","journal-title":"Arthritis Rheum"},{"key":"888_CR69","doi-asserted-by":"publisher","first-page":"4061","DOI":"10.1016\/j.cell.2024.05.034","volume":"187","author":"B Sundaram","year":"2024","unstructured":"Sundaram B, Pandian N, Kim HJ, Abdelaal HM, Mall R, Indari O, Sarkar R, Tweedell RE, Alonzo EQ, Klein J et al (2024) NLRC5 senses NAD(+) depletion, forming a PANoptosome and driving PANoptosis and inflammation. Cell 187:4061\u20134077.e17","journal-title":"Cell"},{"key":"888_CR70","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1016\/j.cell.2023.05.005","volume":"186","author":"B Sundaram","year":"2023","unstructured":"Sundaram B, Pandian N, Mall R, Wang Y, Sarkar R, Kim HJ, Malireddi RKS, Karki R, Janke LJ, Vogel P et al (2023) NLRP12-PANoptosome activates PANoptosis and pathology in response to heme and PAMPs. Cell 186:2783\u20132801.e20","journal-title":"Cell"},{"key":"888_CR71","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","volume":"140","author":"O Takeuchi","year":"2010","unstructured":"Takeuchi O, Akira S (2010) Pattern recognition receptors and inflammation. Cell 140:805\u2013820","journal-title":"Cell"},{"key":"888_CR72","doi-asserted-by":"publisher","DOI":"10.1002\/cpz1.1112","volume":"4","author":"RE Tweedell","year":"2024","unstructured":"Tweedell RE, Hibler T, Kanneganti TD (2024) Defining PANoptosis: biochemical and mechanistic evaluation of innate immune cell death activation. Curr Protoc 4:e1112","journal-title":"Curr Protoc"},{"key":"888_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.xgen.2024.100654","volume":"4","author":"MT Ueda","year":"2024","unstructured":"Ueda MT, Inamo J, Miya F, Shimada M, Yamaguchi K, Kochi Y (2024) Functional and dynamic profiling of transcript isoforms reveals essential roles of alternative splicing in interferon response. Cell Genom 4:100654","journal-title":"Cell Genom"},{"key":"888_CR74","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/j.1755-148X.2012.01008.x","volume":"25","author":"D Verma","year":"2012","unstructured":"Verma D, Bivik C, Farahani E, Synnerstad I, Fredrikson M, Enerback C, Rosdahl I, Soderkvist P (2012) Inflammasome polymorphisms confer susceptibility to sporadic malignant melanoma. Pigment Cell Melanoma Res 25:506\u2013513","journal-title":"Pigment Cell Melanoma Res"},{"key":"888_CR75","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41392-024-01980-4","volume":"9","author":"L Wang","year":"2024","unstructured":"Wang L, Zhu Y, Zhang N, Xian Y, Tang Y, Ye J, Reza F, He G, Wen X, Jiang X (2024) The multiple roles of interferon regulatory factor family in health and disease. Signal Transduct Target Ther 9:282","journal-title":"Signal Transduct Target Ther"},{"key":"888_CR76","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2019101996","volume":"38","author":"H Xu","year":"2019","unstructured":"Xu H, Shi J, Gao H, Liu Y, Yang Z, Shao F, Dong N (2019) The N-end rule ubiquitin ligase UBR2 mediates NLRP1B inflammasome activation by anthrax lethal toxin. EMBO J 38:e101996","journal-title":"EMBO J"},{"key":"888_CR77","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1126\/science.1087262","volume":"301","author":"M Yamamoto","year":"2003","unstructured":"Yamamoto M, Sato S, Hemmi H, Hoshino K, Kaisho T, Sanjo H, Takeuchi O, Sugiyama M, Okabe M, Takeda K et al (2003) Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301:640\u2013643","journal-title":"Science"},{"key":"888_CR78","doi-asserted-by":"publisher","first-page":"7741","DOI":"10.1007\/s12035-019-1638-7","volume":"56","author":"JKY Yap","year":"2019","unstructured":"Yap JKY, Pickard BS, Chan EWL, Gan SY (2019) The role of neuronal NLRP1 inflammasome in Alzheimer\u2019s disease: bringing neurons into the neuroinflammation game. Mol Neurobiol 56:7741\u20137753","journal-title":"Mol Neurobiol"},{"key":"888_CR79","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/s41586-023-06532-4","volume":"622","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Shibata T, Fujimura A, Kitaura J, Miyake K, Ohto U, Shimizu T (2023) Structural basis for thioredoxin-mediated suppression of NLRP1 inflammasome. Nature 622:188\u2013194","journal-title":"Nature"},{"key":"888_CR80","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.cell.2016.09.001","volume":"167","author":"FL Zhong","year":"2016","unstructured":"Zhong FL, Mamai O, Sborgi L, Boussofara L, Hopkins R, Robinson K, Szeverenyi I, Takeichi T, Balaji R, Lau A et al (2016) Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation. Cell 167:187\u2013202.e17","journal-title":"Cell"},{"key":"888_CR81","doi-asserted-by":"publisher","first-page":"18864","DOI":"10.1074\/jbc.RA118.004350","volume":"293","author":"FL Zhong","year":"2018","unstructured":"Zhong FL, Robinson K, Teo DET, Tan KY, Lim C, Harapas CR, Yu CH, Xie WH, Sobota RM, Au VB et al (2018) Human DPP9 represses NLRP1 inflammasome and protects against autoinflammatory diseases via both peptidase activity and FIIND domain binding. J Biol Chem 293:18864\u201318878","journal-title":"J Biol Chem"},{"key":"888_CR82","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.humimm.2010.02.004","volume":"71","author":"M Zurawek","year":"2010","unstructured":"Zurawek M, Fichna M, Januszkiewicz-Lewandowska D, Gryczynska M, Fichna P, Nowak J (2010) A coding variant in NLRP1 is associated with autoimmune Addison\u2019s disease. Hum Immunol 71:530\u2013534","journal-title":"Hum Immunol"}],"container-title":["EMBO Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44319-026-00888-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44319-026-00888-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44319-026-00888-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:33:22Z","timestamp":1790145202000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44319-026-00888-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":82,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2026,9,23]]}},"alternative-id":["888"],"URL":"https:\/\/doi.org\/10.1038\/s44319-026-00888-0","relation":{},"ISSN":["1469-3178"],"issn-type":[{"value":"1469-3178","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]},"assertion":[{"value":"4 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}]}}